These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis. Calanna S, Piro S, Di Pino A, Maria Zagami R, Urbano F, Purrello F, Maria Rabuazzo A. Obesity (Silver Spring); 2013 Feb; 21(2):320-5. PubMed ID: 23404781 [Abstract] [Full Text] [Related]
9. Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance. Ebert R, Frerichs H, Creutzfeldt W. Eur J Clin Invest; 1979 Apr; 9(2 Pt 1):129-35. PubMed ID: 111943 [Abstract] [Full Text] [Related]
10. Gastric inhibitory polypeptide responses to nutrients in Caucasians and American Indians with obesity and noninsulin-dependent diabetes mellitus. Mazzaferri EL, Starich GH, Lardinois CK, Bowen GD. J Clin Endocrinol Metab; 1985 Aug; 61(2):313-21. PubMed ID: 4008608 [Abstract] [Full Text] [Related]
11. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes. Nauck MA, El-Ouaghlidi A, Gabrys B, Hücking K, Holst JJ, Deacon CF, Gallwitz B, Schmidt WE, Meier JJ. Regul Pept; 2004 Nov 15; 122(3):209-17. PubMed ID: 15491793 [Abstract] [Full Text] [Related]
12. [Application of hyperglycemic clamp technique in the assessment of beta-cell function in obese individuals with glucose intolerance]. Bao YQ, Jia WP, Zhu M, Lu JX, Chen L, Xiang KS. Zhonghua Yi Xue Za Zhi; 2004 Nov 02; 84(21):1781-4. PubMed ID: 15631773 [Abstract] [Full Text] [Related]
13. Hypersecretion of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide in obese patients. Fukase N, Igarashi M, Takahashi H, Manaka H, Yamatani K, Daimon M, Tominaga M, Sasaki H. Diabet Med; 1993 Nov 02; 10(1):44-9. PubMed ID: 8435987 [Abstract] [Full Text] [Related]
14. Effects of physical training on insulin, connecting peptide (C-peptide), gastric inhibitory polypeptide (GIP) and pancreatic polypeptide (PP) levels in obese subjects. Krotkiewski M, Björntorp P, Holm G, Marks V, Morgan L, Smith U, Feurle GE. Int J Obes; 1984 Nov 02; 8(3):193-9. PubMed ID: 6378815 [Abstract] [Full Text] [Related]
15. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin. Svendsen PF, Nilas L, Madsbad S, Holst JJ. Metabolism; 2009 May 02; 58(5):586-93. PubMed ID: 19375579 [Abstract] [Full Text] [Related]
16. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype. Vilsbøll T, Knop FK, Krarup T, Johansen A, Madsbad S, Larsen S, Hansen T, Pedersen O, Holst JJ. J Clin Endocrinol Metab; 2003 Oct 02; 88(10):4897-903. PubMed ID: 14557471 [Abstract] [Full Text] [Related]
17. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance. Vollmer K, Holst JJ, Baller B, Ellrichmann M, Nauck MA, Schmidt WE, Meier JJ. Diabetes; 2008 Mar 02; 57(3):678-87. PubMed ID: 18057091 [Abstract] [Full Text] [Related]